Tumor Necrosis Factor-alpha
"Tumor Necrosis Factor-alpha" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS.
| Descriptor ID |
D014409
|
| MeSH Number(s) |
D12.644.276.374.500.800 D12.644.276.374.750.626 D12.776.124.900 D12.776.395.930 D12.776.467.374.500.800 D12.776.467.374.750.626 D23.529.374.500.800 D23.529.374.750.626
|
| Concept/Terms |
Tumor Necrosis Factor-alpha- Tumor Necrosis Factor-alpha
- Tumor Necrosis Factor alpha
- Cachectin
- Cachectin-Tumor Necrosis Factor
- Cachectin Tumor Necrosis Factor
- Tumor Necrosis Factor Ligand Superfamily Member 2
- Tumor Necrosis Factor
- TNF Superfamily, Member 2
- TNFalpha
- TNF-alpha
|
Below are MeSH descriptors whose meaning is more general than "Tumor Necrosis Factor-alpha".
Below are MeSH descriptors whose meaning is more specific than "Tumor Necrosis Factor-alpha".
This graph shows the total number of publications written about "Tumor Necrosis Factor-alpha" by people in this website by year, and whether "Tumor Necrosis Factor-alpha" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 1 | 4 |
| 1997 | 4 | 5 | 9 |
| 1998 | 2 | 5 | 7 |
| 1999 | 6 | 10 | 16 |
| 2000 | 7 | 9 | 16 |
| 2001 | 8 | 15 | 23 |
| 2002 | 4 | 17 | 21 |
| 2003 | 7 | 17 | 24 |
| 2004 | 5 | 20 | 25 |
| 2005 | 9 | 15 | 24 |
| 2006 | 4 | 13 | 17 |
| 2007 | 5 | 14 | 19 |
| 2008 | 12 | 11 | 23 |
| 2009 | 4 | 14 | 18 |
| 2010 | 5 | 16 | 21 |
| 2011 | 8 | 11 | 19 |
| 2012 | 3 | 15 | 18 |
| 2013 | 5 | 14 | 19 |
| 2014 | 5 | 6 | 11 |
| 2015 | 5 | 14 | 19 |
| 2016 | 3 | 10 | 13 |
| 2017 | 2 | 7 | 9 |
| 2018 | 2 | 10 | 12 |
| 2019 | 2 | 13 | 15 |
| 2020 | 2 | 8 | 10 |
| 2021 | 0 | 7 | 7 |
| 2022 | 1 | 11 | 12 |
| 2023 | 1 | 4 | 5 |
| 2024 | 1 | 5 | 6 |
| 2025 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tumor Necrosis Factor-alpha" by people in Profiles.
-
Inflammation and dimensions of fatigue in women with early stage breast cancer: A longitudinal examination. Cancer. 2025 Oct 15; 131(20):e70038.
-
Characterization of hepatic pathology during azoxymethane-induced acute liver failure. World J Gastroenterol. 2025 Mar 28; 31(12):103952.
-
Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes. Cardiovasc Res. 2024 10 14; 120(12):1456-1471.
-
Failure Rate of Anti-Tumor Necrosis Factor a Biologics in Very Early Onset Inflammatory Bowel Disease. Inflamm Bowel Dis. 2024 03 01; 30(3):510-512.
-
A TNF-IL-1 circuit controls Yersinia within intestinal pyogranulomas. J Exp Med. 2024 Mar 04; 221(3).
-
Genetic variants associated with dengue hemorrhagic fever. A systematic review and meta-analysis. J Infect Public Health. 2024 Apr; 17(4):579-587.
-
Cytokine Release by Microglia Exposed to Neurologic Injury Is Amplified by Lipopolysaccharide. J Surg Res. 2024 Apr; 296:142-148.
-
[Zhuyu Pills promote polarization of macrophages toward M2 phenotype to prevent atherosclerosis via PPAR?/NF-?B signaling pathway]. Zhongguo Zhong Yao Za Zhi. 2024 Jan; 49(1):243-250.
-
TNF is a critical cytokine in age-related dry eye disease. Ocul Surf. 2023 10; 30:119-128.
-
Hyperglycemia: A determinant of cardiac autonomic dysfunction in youth with obesity across the spectrum of glycemic regulation. Pediatr Obes. 2023 10; 18(10):e13063.